Anti-malarial drugs (also called anti-malarials) are medications used for the treatment and prevention of malaria infection.
On the one hand, they are used for routine intermittent treatment of specific groups in endemic regions. On the other, the drug can prevent the infection in individuals who travel or visit a malaria-endemic region
In 2019, the market size of Anti-Malarial Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Malarial Drug.
This report studies the global market size of Anti-Malarial Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Malarial Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer
Market Segment by Product Type
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Market Segment by Application
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-Malarial Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Malarial Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-Malarial Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
On the one hand, they are used for routine intermittent treatment of specific groups in endemic regions. On the other, the drug can prevent the infection in individuals who travel or visit a malaria-endemic region
In 2019, the market size of Anti-Malarial Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Malarial Drug.
This report studies the global market size of Anti-Malarial Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Malarial Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer
Market Segment by Product Type
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Market Segment by Application
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-Malarial Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Malarial Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-Malarial Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-Malarial Drug Market Size Growth Rate by Type (2019-2025)
1.3.2 Plasmodium Falciparum
1.3.3 Plasmodium Vivax
1.3.4 Plasmodium Malariae
1.3.5 Plasmodium Ovale
1.4 Market Segment by Application
1.4.1 Global Anti-Malarial Drug Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 E-Commerce
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Malarial Drug Market Size
2.1.1 Global Anti-Malarial Drug Revenue 2014-2025
2.1.2 Global Anti-Malarial Drug Sales 2014-2025
2.2 Anti-Malarial Drug Growth Rate by Regions
2.2.1 Global Anti-Malarial Drug Sales by Regions 2014-2019
2.2.2 Global Anti-Malarial Drug Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-Malarial Drug Sales by Manufacturers
3.1.1 Anti-Malarial Drug Sales by Manufacturers 2014-2019
3.1.2 Anti-Malarial Drug Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anti-Malarial Drug Revenue by Manufacturers (2014-2019)
3.2.2 Anti-Malarial Drug Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anti-Malarial Drug Market Concentration Ratio (CR5 and HHI)
3.3 Anti-Malarial Drug Price by Manufacturers
3.4 Key Manufacturers Anti-Malarial Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-Malarial Drug Market
3.6 Key Manufacturers Anti-Malarial Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Plasmodium Falciparum Sales and Revenue (2014-2019)
4.1.2 Plasmodium Vivax Sales and Revenue (2014-2019)
4.1.3 Plasmodium Malariae Sales and Revenue (2014-2019)
4.1.4 Plasmodium Ovale Sales and Revenue (2014-2019)
4.2 Global Anti-Malarial Drug Sales Market Share by Type
4.3 Global Anti-Malarial Drug Revenue Market Share by Type
4.4 Anti-Malarial Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-Malarial Drug Sales by Application
6 United States
6.1 United States Anti-Malarial Drug Breakdown Data by Company
6.2 United States Anti-Malarial Drug Breakdown Data by Type
6.3 United States Anti-Malarial Drug Breakdown Data by Application
7 European Union
7.1 European Union Anti-Malarial Drug Breakdown Data by Company
7.2 European Union Anti-Malarial Drug Breakdown Data by Type
7.3 European Union Anti-Malarial Drug Breakdown Data by Application
8 China
8.1 China Anti-Malarial Drug Breakdown Data by Company
8.2 China Anti-Malarial Drug Breakdown Data by Type
8.3 China Anti-Malarial Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-Malarial Drug Breakdown Data by Company
9.2 Rest of World Anti-Malarial Drug Breakdown Data by Type
9.3 Rest of World Anti-Malarial Drug Breakdown Data by Application
9.4 Rest of World Anti-Malarial Drug Breakdown Data by Countries
9.4.1 Rest of World Anti-Malarial Drug Sales by Countries
9.4.2 Rest of World Anti-Malarial Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.1.4 Anti-Malarial Drug Product Introduction
10.1.5 GlaxoSmithKline Recent Development
10.2 Ranbaxy
10.2.1 Ranbaxy Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.2.4 Anti-Malarial Drug Product Introduction
10.2.5 Ranbaxy Recent Development
10.3 Zydus Cadila
10.3.1 Zydus Cadila Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.3.4 Anti-Malarial Drug Product Introduction
10.3.5 Zydus Cadila Recent Development
10.4 Alvizia
10.4.1 Alvizia Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.4.4 Anti-Malarial Drug Product Introduction
10.4.5 Alvizia Recent Development
10.5 Bayer
10.5.1 Bayer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.5.4 Anti-Malarial Drug Product Introduction
10.5.5 Bayer Recent Development
10.6 Ipca
10.6.1 Ipca Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.6.4 Anti-Malarial Drug Product Introduction
10.6.5 Ipca Recent Development
10.7 Merck
10.7.1 Merck Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.7.4 Anti-Malarial Drug Product Introduction
10.7.5 Merck Recent Development
10.8 F. Hoffmann-La Roche
10.8.1 F. Hoffmann-La Roche Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.8.4 Anti-Malarial Drug Product Introduction
10.8.5 F. Hoffmann-La Roche Recent Development
10.9 Novartis
10.9.1 Novartis Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.9.4 Anti-Malarial Drug Product Introduction
10.9.5 Novartis Recent Development
10.10 Pfizer
10.10.1 Pfizer Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.10.4 Anti-Malarial Drug Product Introduction
10.10.5 Pfizer Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anti-Malarial Drug Sales Channels
11.2.2 Anti-Malarial Drug Distributors
11.3 Anti-Malarial Drug Customers
12 Market Forecast
12.1 Global Anti-Malarial Drug Sales and Revenue Forecast 2019-2025
12.2 Global Anti-Malarial Drug Sales Forecast by Type
12.3 Global Anti-Malarial Drug Sales Forecast by Application
12.4 Anti-Malarial Drug Forecast by Regions
12.4.1 Global Anti-Malarial Drug Sales Forecast by Regions 2019-2025
12.4.2 Global Anti-Malarial Drug Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-Malarial Drug Market Size Growth Rate by Type (2019-2025)
1.3.2 Plasmodium Falciparum
1.3.3 Plasmodium Vivax
1.3.4 Plasmodium Malariae
1.3.5 Plasmodium Ovale
1.4 Market Segment by Application
1.4.1 Global Anti-Malarial Drug Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 E-Commerce
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Malarial Drug Market Size
2.1.1 Global Anti-Malarial Drug Revenue 2014-2025
2.1.2 Global Anti-Malarial Drug Sales 2014-2025
2.2 Anti-Malarial Drug Growth Rate by Regions
2.2.1 Global Anti-Malarial Drug Sales by Regions 2014-2019
2.2.2 Global Anti-Malarial Drug Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-Malarial Drug Sales by Manufacturers
3.1.1 Anti-Malarial Drug Sales by Manufacturers 2014-2019
3.1.2 Anti-Malarial Drug Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anti-Malarial Drug Revenue by Manufacturers (2014-2019)
3.2.2 Anti-Malarial Drug Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anti-Malarial Drug Market Concentration Ratio (CR5 and HHI)
3.3 Anti-Malarial Drug Price by Manufacturers
3.4 Key Manufacturers Anti-Malarial Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-Malarial Drug Market
3.6 Key Manufacturers Anti-Malarial Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Plasmodium Falciparum Sales and Revenue (2014-2019)
4.1.2 Plasmodium Vivax Sales and Revenue (2014-2019)
4.1.3 Plasmodium Malariae Sales and Revenue (2014-2019)
4.1.4 Plasmodium Ovale Sales and Revenue (2014-2019)
4.2 Global Anti-Malarial Drug Sales Market Share by Type
4.3 Global Anti-Malarial Drug Revenue Market Share by Type
4.4 Anti-Malarial Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-Malarial Drug Sales by Application
6 United States
6.1 United States Anti-Malarial Drug Breakdown Data by Company
6.2 United States Anti-Malarial Drug Breakdown Data by Type
6.3 United States Anti-Malarial Drug Breakdown Data by Application
7 European Union
7.1 European Union Anti-Malarial Drug Breakdown Data by Company
7.2 European Union Anti-Malarial Drug Breakdown Data by Type
7.3 European Union Anti-Malarial Drug Breakdown Data by Application
8 China
8.1 China Anti-Malarial Drug Breakdown Data by Company
8.2 China Anti-Malarial Drug Breakdown Data by Type
8.3 China Anti-Malarial Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-Malarial Drug Breakdown Data by Company
9.2 Rest of World Anti-Malarial Drug Breakdown Data by Type
9.3 Rest of World Anti-Malarial Drug Breakdown Data by Application
9.4 Rest of World Anti-Malarial Drug Breakdown Data by Countries
9.4.1 Rest of World Anti-Malarial Drug Sales by Countries
9.4.2 Rest of World Anti-Malarial Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.1.4 Anti-Malarial Drug Product Introduction
10.1.5 GlaxoSmithKline Recent Development
10.2 Ranbaxy
10.2.1 Ranbaxy Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.2.4 Anti-Malarial Drug Product Introduction
10.2.5 Ranbaxy Recent Development
10.3 Zydus Cadila
10.3.1 Zydus Cadila Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.3.4 Anti-Malarial Drug Product Introduction
10.3.5 Zydus Cadila Recent Development
10.4 Alvizia
10.4.1 Alvizia Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.4.4 Anti-Malarial Drug Product Introduction
10.4.5 Alvizia Recent Development
10.5 Bayer
10.5.1 Bayer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.5.4 Anti-Malarial Drug Product Introduction
10.5.5 Bayer Recent Development
10.6 Ipca
10.6.1 Ipca Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.6.4 Anti-Malarial Drug Product Introduction
10.6.5 Ipca Recent Development
10.7 Merck
10.7.1 Merck Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.7.4 Anti-Malarial Drug Product Introduction
10.7.5 Merck Recent Development
10.8 F. Hoffmann-La Roche
10.8.1 F. Hoffmann-La Roche Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.8.4 Anti-Malarial Drug Product Introduction
10.8.5 F. Hoffmann-La Roche Recent Development
10.9 Novartis
10.9.1 Novartis Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.9.4 Anti-Malarial Drug Product Introduction
10.9.5 Novartis Recent Development
10.10 Pfizer
10.10.1 Pfizer Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anti-Malarial Drug
10.10.4 Anti-Malarial Drug Product Introduction
10.10.5 Pfizer Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anti-Malarial Drug Sales Channels
11.2.2 Anti-Malarial Drug Distributors
11.3 Anti-Malarial Drug Customers
12 Market Forecast
12.1 Global Anti-Malarial Drug Sales and Revenue Forecast 2019-2025
12.2 Global Anti-Malarial Drug Sales Forecast by Type
12.3 Global Anti-Malarial Drug Sales Forecast by Application
12.4 Anti-Malarial Drug Forecast by Regions
12.4.1 Global Anti-Malarial Drug Sales Forecast by Regions 2019-2025
12.4.2 Global Anti-Malarial Drug Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
